Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sevion Therapeutics Inc (OTCQB:SVON)

0.1985
Delayed Data
As of Apr 24
 +0.0275 / +16.08%
Today’s Change
0.08
Today|||52-Week Range
0.30
+41.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.1M

Company Description

Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA.

Contact Information

Sevion Therapeutics, Inc.
10210 Campus Point Drive
San Diego California 92121
P:(858) 909-0749
Investor Relations:

Employees

Shareholders

Individual stakeholders14.10%
Mutual fund holders--
Other institutional--

Top Executives

David S. RectorPresident, Chief Executive Officer & Director
James R. SchmidtChief Financial Officer
James Joseph GrazianoChief Technology Officer
Vaughn V. SmiderDirector & Chief Scientific Officer
Miguel A. de los RĂ­osVice President-Research & Development